‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.Barriers to use of smoking cessation therapies in pregnancy
Women are required to stop some smoking cessation pharmacotherapies when they find out they are pregnant. Here's what needs to change.
Can pharmacists help prevent doping in sport?
The recent release of the updated 2019 List of Prohibited Substances and Methods from the World-Anti-Doping Agency (WADA) raises the question about the relationship...
PSA recommendations to improve medicine use in disability care
A critical lack of information about medicine use by people with disability prevents pharmacists from promoting the quality use of medicines within a vulnerable group.
Balancing the scale: the role of oral anticoagulants in atrial fibrillation
Atrial fibrillation is the most common recurrent arrhythmia worldwide, and can put patients at increased risk of stroke.
Pharmacists funded under new medicine safety trial
A new intervention will target medicine safety in primary care, with the aim of reducing medicine-related hospitalisations by identifying at-risk patients.
New beginnings for PSA’s Pharmacist of the Year
Congratulations PSA Pharmacist of the Year Faye McMillan MPS for her appointment as Professor of Indigenous Health at UTS.
